Meira, M., Sievers, C., Hoffmann, F., Rasenack, M., Kuhle, J., Derfuss, T., . . . Lindberg, R. L. P. (2014). Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4(+) T Cells of Patients with Relapsing-Remitting Multiple Sclerosis. Hindawi Publishing Corporation.
Citação norma ChicagoMeira, Maria, Claudia Sievers, Francine Hoffmann, Maria Rasenack, Jens Kuhle, Tobias Derfuss, Ludwig Kappos, and Raija L. P. Lindberg. Unraveling Natalizumab Effects On Deregulated MiR-17 Expression in CD4(+) T Cells of Patients With Relapsing-Remitting Multiple Sclerosis. Hindawi Publishing Corporation, 2014.
MLA citiranjeMeira, Maria, et al. Unraveling Natalizumab Effects On Deregulated MiR-17 Expression in CD4(+) T Cells of Patients With Relapsing-Remitting Multiple Sclerosis. Hindawi Publishing Corporation, 2014.